Related Experiment Videos
Current status of clinical development of interleukin-10
1First Department of Medicine, University of Vienna, Austria.
Insights
Interleukin-10 (IL-10) is a cytokine that suppresses inflammation and immune responses. Research shows IL-10 has therapeutic potential for diseases driven by excessive cytokine production.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Cellular communication in the lymphohematopoietic system relies on cytokines.
- Interleukin-10 (IL-10) acts as a negative feedback regulator, inhibiting pro-inflammatory cytokine and colony-stimulating factor synthesis.
- IL-10's immunosuppressive effects are observed in various immune cells like macrophages, T cells, neutrophils, and eosinophils.
Purpose of the Study:
- To review the role of Interleukin-10 (IL-10) in cellular communication and immune regulation.
- To summarize recent advancements in understanding IL-10 receptor interactions and signal transduction.
- To explore the therapeutic potential of IL-10 in cytokine-mediated diseases.
Main Methods:
- Literature review of studies on Interleukin-10 (IL-10).
- Analysis of in vitro and preclinical data regarding IL-10's effects.
- Characterization of IL-10 receptor and downstream signaling pathways.
Main Results:
- Interleukin-10 (IL-10) demonstrates significant cytokine synthesis-inhibiting activity.
- Recent studies have elucidated the IL-10 receptor and its signal transduction mechanisms.
- Preclinical evidence supports IL-10's utility in managing inflammatory and malignant conditions.
Conclusions:
- Interleukin-10 (IL-10) plays a crucial role in immune system regulation through immunosuppression.
- Understanding IL-10 signaling pathways opens avenues for targeted therapeutic strategies.
- IL-10 holds promise for treating diseases characterized by cytokine overexpression, such as inflammatory bowel disease, pancreatitis, septic shock, and cancers.
Abstract:
Communication between cells in the lymphohematopoietic system is mediated by soluble molecules called cytokines. Lymphoid and myeloid cells are the cellular targets and source of these regulatory molecules. Interleukin-10 seems to be a main factor of a negative feedback system that inhibits synthesis of proinflammatory cytokines and of colony-stimulating factors in a variety of cells. Considering the cytokine synthesis-inhibiting action of interleukin-10 in activated macrophages, T cells, neutrophils, and eosinophils, many of the biologic effects of interleukin-10 may result in immunosuppression. Recently, the interleukin-10 receptor and some signal transduction events following interleukin-10 binding have been characterized. Substantial progress has also been made in providing the experimental basis for interleukin-10 therapy in various diseases. In vitro and preclinical studies suggest that interleukin-10 may prove quite useful in clinical settings in which overexpression of cytokines is likely to play an important role in pathogenesis, including inflammatory bowel disease, acute pancreatitis, septic shock, and certain malignancies.